BlackRock
MTCR

BlackRock’s Metacrine, Inc. Common Stock MTCR Stock Holding History

BlackRock’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,444
Closed -$45K – 5810
2022
Q4 		$45K Hold
100,444
– – ﹤0.01% 5254
2022
Q3 		$48K Hold
100,444
– – ﹤0.01% 5371
2022
Q2 		$51K Sell
100,444
-39,427
-28% -$19.1K ﹤0.01% 5411
2022
Q1 		$85K Sell
139,871
-1,926
-1% -$1.01K ﹤0.01% 5320
2021
Q4 		$95K Buy
141,797
+3,878
+3% +$6.92K ﹤0.01% 5288
2021
Q3 		$473K Buy
137,919
+22,795
+20% +$71.1K ﹤0.01% 4768
2021
Q2 		$438K Sell
115,124
-214,242
-65% -$886K ﹤0.01% 4724
2021
Q1 		$2.04M Buy
329,366
+40,795
+14% +$361K ﹤0.01% 4282
2020
Q4 		$2.27M Buy
288,571
+199,750
+225% +$1.83M ﹤0.01% 3994
2020
Q3 		$906K Buy
+88,821
New +$909K ﹤0.01% 4141

Other funds holding MTCR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

BlackRock's MTCR Position: Q1 2023 in Review

BlackRock sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 100,444 shares — an estimated $45K sold.

BlackRock first reported a position in MTCR in Q3 2020 and held it in 10 quarters. The position peaked at $2.27M in Q4 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • BlackRock reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 100,444 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $45K.
  • BlackRock first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • BlackRock's Metacrine, Inc. Common Stock position peaked at $2.27M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.